Numis at a glance

Latest Transactions
Caretech Holdings
Recommended cash offer for CareTech for approximately £870m
June 2022
Appointed Corporate Broker
June 2022

Sales & Research

We have highly regarded and experienced Research analysts who, alongside our first-class Sales team, provide clients with high quality analysis and insights allowing them to make better informed investment decisions.

Meet our Department Heads

(Existing clients can access our Research Portal via the "Client Login" button.)

“I am immensely proud of the depth of knowledge and capability of all of our Research teams. I know that when talking to investors they will provide the sharpest insights, based on a dedication to an outstanding understanding the sectors that they cover”.

Will Wallis Head of Research

Leading the way in UK Equities Research

Our award-winning Research department is exceptionally well regarded throughout the industry. We are consistently ranked amongst the top 3 providers, and were again in the 2020 Extel Mid & Small-Cap survey, continuing a long tradition of outstanding recognition.

We cover around 300 UK companies, ranging across all sizes and the majority of sectors, and have developed a growing footprint into a number of privately-owned businesses.

Our research continues to go from strength to strength – it’s a critical part of our connected offering

Research that digs deeper

Our analysts invest significant amounts of time talking to companies and investors, formulating a comprehensive understanding and distilling this into written work that delivers intelligence. The median length of sell-side Research experience within our team is close to twenty years.

Strengthening post change

As the volume of research post-MiFID II narrows, our distribution has expanded whereas others have seen contraction. We are well-positioned to continue capitalising on the quality and granularity of our analysis.

Unrivalled investor connectivity

We have also continued to invest in our experienced Equity Sales capability with the largest dedicated UK Equity team in the market, based in London and New York. The depth of our relationships across Europe and the US provides us with comprehensive insights into current shareholder views about listed companies as well as enabling us to target future shareholders with carefully crafted roadshows and content. Our innovative and flexible approach has also seen our network extend into retail fund managers and regional pension funds via our dedicated PFCM service.

“Numis is an excellent broker for the buy-side. They have strong research and an experienced sales staff that truly understands how companies operate. It is clear to our investment team that Numis provides the best overall coverage of the UK market”.


Nick Stockman

Head of UK Equity Sales

Email Nick

Edward Husband

Head of US Sales

Email Edward

Simon Bowler

Head of Research

Email Simon

Looking for someone else in the team?

Our equities contacts can help.

For the last ten years, we have been rated in the top 3 in the Extel survey for small capitalisation UK stocks.
Extel Results 2020

Between 2013 - 2018 we were voted the top-ranked UK Small & Mid Cap Brokerage by institutions and in 2014, 2015, 2016 and 2017, we were voted the top-ranked UK Small & Mid Cap Brokerage by both institutions and companies.

Extel 2020

Investment Banking